Use of Clays as Nanocarriers of First-Line Tuberculostatic Drugs

Curr Drug Deliv. 2017;14(7):902-903. doi: 10.2174/1567201813666160714160727.

Authors

Esperanza Carazo¹, Ana Borrego-Sanchez^{1

2}, Carola Aguzzi¹, Pilar Cerezo¹, Cesar Viseras^{1

2}

Affiliations

¹ Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada, Campus of Cartuja, 18071 s/n, Granada, Spain
² Andalusian Institute of Earth Sciences, CSIC-University of Granada, Avda. de Las Palmeras 4, 18100, Armilla (Granada), Spain

PMID: 27515347
DOI: 10.2174/1567201813666160714160727

No abstract available

MeSH terms

Adsorption
Aluminum Silicates / chemistry*
Animals
Antitubercular Agents / pharmacology*
Biological Availability
Clay
Drug Carriers / chemistry*
Drug Stability
Humans
Liver / drug effects
Mycobacterium tuberculosis / drug effects
Nanocomposites / chemistry
Treatment Outcome
Tuberculosis / drug therapy*
Tuberculosis / microbiology

Substances

Aluminum Silicates
Antitubercular Agents
Drug Carriers
Clay